These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

346 related articles for article (PubMed ID: 18238793)

  • 1. Signalling, inflammation and arthritis: crossed signals: the role of interleukin (IL)-12, -17, -23 and -27 in autoimmunity.
    Paunovic V; Carroll HP; Vandenbroeck K; Gadina M
    Rheumatology (Oxford); 2008 Jun; 47(6):771-6. PubMed ID: 18238793
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cytokine inhibitors in rheumatoid arthritis and other autoimmune diseases.
    Williams RO; Paleolog E; Feldmann M
    Curr Opin Pharmacol; 2007 Aug; 7(4):412-7. PubMed ID: 17627887
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Th17 cytokines and their emerging roles in inflammation and autoimmunity.
    Fouser LA; Wright JF; Dunussi-Joannopoulos K; Collins M
    Immunol Rev; 2008 Dec; 226():87-102. PubMed ID: 19161418
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A positive feedback loop of IL-21 signaling provoked by homeostatic CD4+CD25- T cell expansion is essential for the development of arthritis in autoimmune K/BxN mice.
    Jang E; Cho SH; Park H; Paik DJ; Kim JM; Youn J
    J Immunol; 2009 Apr; 182(8):4649-56. PubMed ID: 19342640
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Th17 cells in rheumatoid arthritis and systemic lupus erythematosus.
    Pernis AB
    J Intern Med; 2009 Jun; 265(6):644-52. PubMed ID: 19493058
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular mechanisms of inflammatory bone damage: emerging targets for therapy.
    Herman S; Krönke G; Schett G
    Trends Mol Med; 2008 Jun; 14(6):245-53. PubMed ID: 18468489
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Regulation of cytokine production during phagocytosis of apoptotic cells.
    Chung EY; Kim SJ; Ma XJ
    Cell Res; 2006 Feb; 16(2):154-61. PubMed ID: 16474428
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The IL-23/Th(17) axis: therapeutic targets for autoimmune inflammation.
    Kikly K; Liu L; Na S; Sedgwick JD
    Curr Opin Immunol; 2006 Dec; 18(6):670-5. PubMed ID: 17010592
    [TBL] [Abstract][Full Text] [Related]  

  • 9. IL-17 and IL-22: siblings, not twins.
    Eyerich S; Eyerich K; Cavani A; Schmidt-Weber C
    Trends Immunol; 2010 Sep; 31(9):354-61. PubMed ID: 20691634
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rationale and safety of anti-interleukin-23 and anti-interleukin-17A therapy.
    Bowman EP; Chackerian AA; Cua DJ
    Curr Opin Infect Dis; 2006 Jun; 19(3):245-52. PubMed ID: 16645485
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Update on cytokines in rheumatoid arthritis.
    Brennan F; Beech J
    Curr Opin Rheumatol; 2007 May; 19(3):296-301. PubMed ID: 17414959
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cytokines in the pathogenesis of rheumatoid arthritis.
    McInnes IB; Schett G
    Nat Rev Immunol; 2007 Jun; 7(6):429-42. PubMed ID: 17525752
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cytokine signal regulation and autoimmune disorders.
    Nishimoto N
    Autoimmunity; 2005 Aug; 38(5):359-67. PubMed ID: 16227151
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Signalling, inflammation and arthritis: Crossed signals: the role of interleukin-15 and -18 in autoimmunity.
    Carroll HP; Paunovic V; Gadina M
    Rheumatology (Oxford); 2008 Sep; 47(9):1269-77. PubMed ID: 18621751
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neutralizing IL-21 and IL-15 inhibits pro-inflammatory cytokine production in rheumatoid arthritis.
    Andersson AK; Feldmann M; Brennan FM
    Scand J Immunol; 2008 Jul; 68(1):103-11. PubMed ID: 18482208
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interleukin-12 family members and type I interferons in Th17-mediated inflammatory disorders.
    Goriely S; Cavoy R; Goldman M
    Allergy; 2009 May; 64(5):702-9. PubMed ID: 19383026
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Targeting IL-23 in autoimmunity.
    Hölscher C
    Curr Opin Investig Drugs; 2005 May; 6(5):489-95. PubMed ID: 15912962
    [TBL] [Abstract][Full Text] [Related]  

  • 18. IL-19, IL-20 and IL-24: potential therapeutic targets for autoimmune diseases.
    Leng RX; Pan HF; Tao JH; Ye DQ
    Expert Opin Ther Targets; 2011 Feb; 15(2):119-26. PubMed ID: 21073280
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interleukin-21 as a new therapeutic target for immune-mediated diseases.
    Monteleone G; Pallone F; Macdonald TT
    Trends Pharmacol Sci; 2009 Aug; 30(8):441-7. PubMed ID: 19616319
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Emerging cytokine targets in rheumatoid arthritis.
    Asquith DL; McInnes IB
    Curr Opin Rheumatol; 2007 May; 19(3):246-51. PubMed ID: 17414950
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.